HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alexander Nyström Selected Research
Alexander Nyström Research Topics
Disease
18
Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
01/2022 - 01/2013
9
Fibrosis (Cirrhosis)
01/2022 - 09/2015
9
Neoplasms (Cancer)
01/2021 - 01/2008
7
Wounds and Injuries (Trauma)
08/2021 - 01/2016
5
Inflammation (Inflammations)
05/2020 - 09/2015
3
Inborn Genetic Diseases (Disease, Hereditary)
01/2022 - 01/2016
3
Skin Diseases (Skin Disease)
01/2021 - 01/2013
3
Epidermolysis Bullosa
06/2019 - 01/2013
2
Cicatrix (Scar)
01/2022 - 01/2021
2
Muscular Dystrophies (Muscular Dystrophy)
08/2006 - 09/2005
1
Carcinoma (Carcinomatosis)
01/2022
1
Common Variable Immunodeficiency
01/2022
1
Autoimmune Lymphoproliferative Syndrome
01/2022
1
Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa)
01/2022
1
Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
06/2019
1
Foot Deformities (Foot Deformity)
01/2019
1
Disease Progression
01/2019
1
Adenocarcinoma
01/2019
1
Congenital Abnormalities (Deformity)
01/2019
1
Hypertension (High Blood Pressure)
11/2018
1
Skin Manifestations
10/2018
1
Wound Infection (Wound Infections)
01/2018
1
Papilloma (Papillomatosis)
02/2016
1
Carcinogenesis
02/2016
1
Blister (Bulla)
11/2014
1
Male Infertility (Male Sterility)
09/2005
Drug/Important Bio-Agent (IBA)
17
Collagen
IBA
01/2022 - 01/2013
9
Proteins (Proteins, Gene)
FDA Link
01/2022 - 01/2013
4
Integrins
IBA
01/2021 - 08/2006
4
Collagen Type VII
IBA
01/2019 - 11/2014
3
Proteome
IBA
10/2021 - 01/2018
2
Antisense Oligonucleotides
IBA
01/2021 - 10/2016
2
Decorin
IBA
01/2019 - 05/2009
2
Biological Products
IBA
10/2018 - 01/2018
2
Collagen Type XVII
IBA
02/2016 - 01/2016
2
Laminin (Merosin)
IBA
08/2006 - 09/2005
1
Extracellular Matrix Proteins
IBA
01/2022
1
Tiopronin (Thiola)
FDA Link
08/2021
1
carbomer
IBA
01/2021
1
Thrombospondin 1
IBA
01/2021
1
Matrix Metalloproteinases (MMPs)
IBA
01/2021
1
Cell Surface Receptors
IBA
11/2020
1
Antibodies
IBA
11/2019
1
Protein Aggregates
IBA
06/2019
1
Keratin-5 (Keratin 5)
IBA
06/2019
1
Keratins (Keratin)
IBA
06/2019
1
4-phenylbutyric acid (Buphenyl)
FDA Link
06/2019
1
Peptide Hydrolases (Proteases)
FDA Link
01/2019
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
01/2019
1
Conditioned Culture Media
IBA
01/2019
1
Disintegrins
IBA
01/2019
1
Metalloproteases (Metalloproteinases)
IBA
01/2019
1
Heparin-binding EGF-like Growth Factor (HB-EGF)
IBA
01/2019
1
Ligands
IBA
11/2018
1
Enzymes
IBA
11/2018
1
Messenger RNA (mRNA)
IBA
01/2018
1
Complement System Proteins (Complement)
IBA
12/2017
1
RNA (Ribonucleic Acid)
IBA
03/2016
1
Protein-Lysine 6-Oxidase (Lysyl Oxidase)
IBA
02/2016
1
Carcinogens
IBA
02/2016
1
Sirolimus (Rapamycin)
FDA Link
01/2016
1
Interleukin-6 (Interleukin 6)
IBA
09/2015
1
Losartan (Cozaar)
FDA Link
Generic
09/2015
1
Glycine (Aminoacetic Acid)
FDA Link
Generic
01/2013
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
11/2009
1
perlecan
IBA
05/2009
1
Collagen Type XVIII (Type XVIII Collagen)
IBA
05/2009
1
Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)
IBA
05/2009
1
Proteoglycans (Proteoglycan)
IBA
05/2009
1
Agrin
IBA
05/2009
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
05/2009
1
ErbB Receptors (EGF Receptor)
IBA
05/2009
1
Small Leucine-Rich Proteoglycans
IBA
05/2009
1
Integrin alpha2beta1
IBA
01/2008
1
laminin alpha 2
IBA
09/2005
Therapy/Procedure
10
Therapeutics
01/2022 - 01/2013
2
Cell- and Tissue-Based Therapy (Cell Therapy)
11/2019 - 11/2014
1
Injections
01/2022
1
Intradermal Injections
11/2014